Aprogen, Inc
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
007460 | KO
Overview
Corporate Details
- ISIN(s):
- KR7007460009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 둔촌대로 545 경기도 성남시 중원구 둔촌대로545, 비1층 (상대원동, 한라시그마밸리), 성남시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aprogen, Inc. is a biopharmaceutical company specializing in the development and manufacturing of biologics. Leveraging proprietary technologies in antibody and recombinant protein engineering, the company creates both novel drugs and biosimilars. Its product pipeline focuses on addressing various medical needs, including treatments for degenerative arthritis and triple-negative breast cancer. Aprogen develops its own portfolio of biologics alongside biosimilar products, aiming to make advanced medicines more accessible in the global pharmaceutical market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-19 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 151.1 KB | ||
| 2025-09-17 00:00 |
Regulatory News Service
투자판단관련주요경영사항
|
Korean | 15.5 KB | ||
| 2025-09-03 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)(자회사의 주요경영사항) (제3자배정)
|
Korean | 31.1 KB | ||
| 2025-08-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 157.0 KB | ||
| 2025-08-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 149.8 KB | ||
| 2025-08-19 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (독점실시권 라이선스 계약(면역항암제 기술도입 계약))
|
Korean | 10.4 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 7.7 MB | ||
| 2025-07-31 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결(자회사의 주요경영사항)
|
Korean | 10.4 KB | ||
| 2025-07-25 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 155.6 KB | ||
| 2025-06-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 148.5 KB | ||
| 2025-06-27 00:00 |
Capital/Financing Update
[기재정정]주권관련사채권의처분결정(종속회사의주요경영사항)
|
Korean | 23.5 KB | ||
| 2025-06-13 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 146.3 KB | ||
| 2025-06-09 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.2 KB | ||
| 2025-06-02 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.2 KB | ||
| 2025-05-30 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 146.4 KB |
Automate Your Workflow. Get a real-time feed of all Aprogen, Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aprogen, Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aprogen, Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Inc./other/Mind_Medicine_MindMed_Inc.-logo.png){kind=logo}
